A

Acumen Pharmaceuticals, Inc.

41 employees

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

amyloid-beta oligomers
Biotechnology
Health Diagnostics
therapeutics
Therapeutics
immunotherapy
Neurodegenerative disease
monoclonal anitbodies
Alzheimer's disease

Date founded

1996

Funding rounds raised

Total raised

$75M

from 5 investors over 5 rounds

A

Acumen Pharmaceuticals, Inc. raised $75M on November 20, 2020

Investors: RA Capital Management, L.P., Sands Capital Management and PBM Capital Group

A

Acumen Pharmaceuticals, Inc. raised $15M on October 24, 2018

Investors: PBM Capital Group and Sands Capital Management

FAQ